Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer

NCT05508568 is registered in ClinicalTrials.gov with Arquer Diagnostics Ltd as lead sponsor.

NCT NCT05508568
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05508568 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer
Lead sponsor
Arquer Diagnostics Ltd
Phase
Observational
Overall status
Unknown status
Start date
July 1, 2021
Completion date
April 30, 2023
Enrollment
650 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer